SCHEMBL3451206

SCHEMBL3451206

CCN[C@@H](Cc1c[nH]c2ccccc12)C(=O)O

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.67
ACE P12821 3/20 0.66
KDM4E B2RXH2 2/20 0.64
MAPT P10636 2/20 0.64
APAF1 O14727 1/20 0.64
POLB P06746 1/20 0.64
RECQL P46063 1/20 0.64
L3MBTL1 Q9Y468 1/20 0.64
ITGB2 P05107 2/20 0.63
ICAM1 P05362 2/20 0.63
ITGAL P20701 2/20 0.63
SMN1; SMN2 Q16637 1/20 0.62
ECE1 P42892 3/20 0.61
FPR2 P25090 1/20 0.61
KMT2A Q03164 3/20 0.60
MEN1 O00255 2/20 0.60
LMNA P02545 1/20 0.60
MPO P05164 1/20 0.60
TSHR P16473 1/20 0.60
BLM P54132 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3451205 1.00 ALOX15 (0.67) ALOX15ACEKDM4EMAPTAPAF1
Acetic Acid SCHEMBL28587208 0.96 ALOX15 (0.67) ALOX15ACEKDM4EMAPTAPAF1
SCHEMBL3851355 0.90 MEN1 (0.66) ALOX15ACEKDM4EMAPTAPAF1
SCHEMBL30523242 0.89 ALOX15 (0.54) ALOX15ACEKDM4EMAPTAPAF1
SCHEMBL12313626 0.89 ALOX15 (0.60) ALOX15ACEKDM4EMAPTAPAF1
SCHEMBL17641895 0.89 ALOX15 (0.60) ALOX15ACEKDM4EMAPTAPAF1
SCHEMBL14374802 0.88 ALOX15 (0.56) ALOX15ACEKDM4EMAPTAPAF1
SCHEMBL9115508 0.88 ALOX15 (0.65) ALOX15ACEKDM4EMAPTAPAF1
SCHEMBL8710928 0.88 SMN1; SMN2 (0.68) ALOX15ACEKDM4EMAPTAPAF1
SCHEMBL22654181 0.88 ALOX15 (0.65) ALOX15ACEKDM4EMAPTAPAF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4568670-A1 SIGMAR1 LIGAND FOR THE TREATMENT OF PANCREATIC CANCER Institut National de la Santé et de la Recherche Médicale (FR) 2025-06-18 EP disclosed
CN-116874515-B Amino acid-BSH targeted hybrid compound, and preparation method and application thereof 重庆高硼生物科技有限公司 2025-03-14 CN disclosed
CN-119470406-A Phthalic dicarboxaldehyde disinfectant concentration detection test paper and preparation method thereof 山东新华莎罗雅生物技术有限公司 2025-02-18 CN disclosed
WO-2024044271-A2 METAL CHELATOR COMPOUNDS, COORDINATION COMPLEXES, AND METHODS OF PREPARATION AND USE THEREOF UNIVERSITY OF PUERTO RICO (US) 2024-02-29 WO disclosed
WO-2024033399-A1 SIGMAR1 LIGAND FOR THE TREATMENT OF PANCREATIC CANCER Institut National de la Santé et de la Recherche Médicale (FR) 2024-02-15 WO disclosed
WO-2024033400-A1 SK2 INHIBITOR FOR THE TREATMENT OF PANCREATIC CANCER Institut National de la Santé et de la Recherche Médicale (FR) 2024-02-15 WO disclosed
EP-4308241-A1 COMBINATION THERAPY FOR CANCER IO Biotech ApS (DK) 2024-01-24 EP disclosed
CN-117396071-A Delivery particles with high core to wall ratio 恩盖普有限公司 2024-01-12 CN disclosed
CN-116874515-A Amino acid-BSH targeted hybrid compound, and preparation method and application thereof 重庆高硼生物科技有限公司 2023-10-13 CN disclosed
CN-113336768-B Multi-target tyrosine kinase inhibitor 深圳海王医药科技研究院有限公司 2022-08-19 CN disclosed
US-5616684-A CYCLIC HEXAPEPTIDE CONTAINING ASPARTIC ACID AND DERIVATIVES, 2-THIENYLGLYCINE, LEUCINE, AND TRYPTOPHAN; ENDOTHELIN RECEPTOR ANTAGONIST TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1997-04-01 US disclosed
EP-0714909-A1 Composition for prophylaxis or treatment of pulmonary circulatory diseases Takeda Chemical Industries, Ltd. (JP) 1996-06-05 EP disclosed
CN-1109780-A Sustained-release preparation of anti-endothelin substance TAKEDA CHEMICAL INDUSTRIES LTD (JP) 1995-10-11 CN disclosed
EP-0662143-A1 MICROORGANISMS FOR THE PRODUCTION OF TRYPTOPHAN AND PROCESS FOR PRODUCING THE SAME. CONSORTIUM ELEKTROCHEM IND (DE) 1995-07-12 EP disclosed
EP-0647449-A1 Sustained-release preparation of anti-endothelin substance Takeda Chemical Industries, Ltd. (JP) 1995-04-12 EP disclosed
EP-0626174-A2 Methods and compositions for the prophylactic and/or therapeutic treatment of organ hypofunction TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1994-11-30 EP disclosed
WO-1994008031-A1 MICROORGANISMS FOR THE PRODUCTION OF TRYPTOPHAN AND PROCESS FOR PRODUCING THE SAME Consortium für elektrochemische Industrie GmbH (DE) 1994-04-14 WO disclosed
EP-0552417-A1 Cyclic peptides and use thereof TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1993-07-28 EP disclosed
EP-0528312-A2 Cyclic peptides and use thereof TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1993-02-24 EP disclosed
EP-0124502-A2 Conjugates of vinblastine and its derivatives, process for their preparation and pharmaceutical compositions containing these conjugates OMNICHEM Société anonyme (BE) 1984-11-07 EP disclosed